CN1269822C - 克鲁兹蛋白酶与其他半胱氨酸蛋白酶的抑制剂 - Google Patents
克鲁兹蛋白酶与其他半胱氨酸蛋白酶的抑制剂 Download PDFInfo
- Publication number
- CN1269822C CN1269822C CNB028038142A CN02803814A CN1269822C CN 1269822 C CN1269822 C CN 1269822C CN B028038142 A CNB028038142 A CN B028038142A CN 02803814 A CN02803814 A CN 02803814A CN 1269822 C CN1269822 C CN 1269822C
- Authority
- CN
- China
- Prior art keywords
- oxo
- hexahydrofuro
- ethyl
- pyrrol
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0101179A GB0101179D0 (en) | 2001-01-17 | 2001-01-17 | Biologically active compounds |
| GB0101179.0 | 2001-01-17 | ||
| US27535901P | 2001-03-13 | 2001-03-13 | |
| US60/275,359 | 2001-03-13 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200610094085XA Division CN1900080A (zh) | 2001-01-17 | 2002-01-17 | 克鲁兹蛋白酶与其他半胱氨酸蛋白酶的抑制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1486320A CN1486320A (zh) | 2004-03-31 |
| CN1269822C true CN1269822C (zh) | 2006-08-16 |
Family
ID=26245571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB028038142A Expired - Fee Related CN1269822C (zh) | 2001-01-17 | 2002-01-17 | 克鲁兹蛋白酶与其他半胱氨酸蛋白酶的抑制剂 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7425562B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1362052B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4608183B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100860067B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1269822C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE356130T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002219397B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0206501A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2436462C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1106640T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60218633T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1362052T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2281516T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL156774A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03006224A (cg-RX-API-DMAC7.html) |
| NO (1) | NO328208B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ526913A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1362052E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2329266C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002057270A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
| WO2002051983A2 (en) | 2000-12-22 | 2002-07-04 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions as cathepsin inhibitors |
| MXPA04002282A (es) | 2001-09-14 | 2005-03-07 | Axis Pharmaceutical Inc | Nuevos compuestos y preparaciones como inhibidores de la catepsina. |
| EP1446392A1 (en) | 2001-11-14 | 2004-08-18 | Aventis Pharmaceuticals, Inc. | Oligopeptides and compositions containing them as cathepsin s inhibitors |
| CN100354276C (zh) * | 2002-07-16 | 2007-12-12 | 阿姆拉医疗有限公司 | 生物活性化合物 |
| US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
| SE0400022D0 (sv) * | 2004-01-08 | 2004-01-08 | Medivir Ab | New compounds |
| DE602005019971D1 (de) * | 2004-01-08 | 2010-04-29 | Medivir Ab | Inhibitoren von cysteinprotease |
| JP2005350417A (ja) * | 2004-06-11 | 2005-12-22 | Dai Ichi Seiyaku Co Ltd | 還元的エーテル化法を用いたピロリジン誘導体の製造法 |
| PL1865940T3 (pl) * | 2005-03-21 | 2013-06-28 | Virobay Inc | Alfa-ketoamidowe związki jako inhibitory proteaz cysteinowych |
| GB0513839D0 (en) * | 2005-07-07 | 2005-08-10 | Medivir Ab | Cysteine protease inhibitors |
| GB0513840D0 (en) * | 2005-07-07 | 2005-08-10 | Medivir Ab | Cysteine protease inhibitors |
| GB0614037D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614044D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614053D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614052D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614073D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614042D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614046D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| WO2008114054A1 (en) * | 2007-03-19 | 2008-09-25 | Medivir Ab | Protease inhibitors |
| US7893067B2 (en) * | 2007-06-27 | 2011-02-22 | Medivir Ab | Cysteine protease inhibitors |
| JP5587790B2 (ja) * | 2008-01-09 | 2014-09-10 | アミュラ セラピューティクス リミティド | 化合物 |
| GB0804702D0 (en) * | 2008-03-13 | 2008-04-16 | Amura Therapeutics Ltd | Compounds |
| GB0804701D0 (en) | 2008-03-13 | 2008-04-16 | Amura Therapeutics Ltd | Compounds |
| US9409880B2 (en) | 2011-01-20 | 2016-08-09 | The Regents Of The University Of Colorado, A Body Corporate | Modulators of TLR3/dsRNA complex and uses thereof |
| CN106963760A (zh) * | 2012-08-30 | 2017-07-21 | 国立大学法人东京大学 | 体内寄生虫防治剂在制备防治体内寄生虫的药物中的用途 |
| CN106279188A (zh) * | 2016-07-21 | 2017-01-04 | 青岛科技大学 | 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652574A (en) * | 1970-04-01 | 1972-03-28 | Abbott Lab | Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof |
| DE3601226A1 (de) * | 1986-01-17 | 1987-07-23 | Bayer Ag | Dihydropyridinlactole, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| RU2137768C1 (ru) * | 1993-12-15 | 1999-09-20 | Мерк энд Ко, Инк. | Ингибиторы hiv протеазы |
| DZ2285A1 (fr) | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
| EP0923535A4 (en) | 1996-08-28 | 2001-01-10 | Smithkline Beecham Corp | CYSTEINE PROTEASE INHIBITORS |
| ZA9711537B (en) | 1996-12-23 | 1998-06-25 | Athena Neurosciences Inc Eli L | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds. |
| AR013079A1 (es) * | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios |
| MA26618A1 (fr) | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | Composes et compositions pharmaceutiques pour le traitement du paludisme |
| CO5150165A1 (es) | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | Inhibidores de proteasa: tipo catepsina k |
| GB9911417D0 (en) * | 1999-05-18 | 1999-07-14 | Peptide Therapeutics Ltd | Furanone derivatives as inhibitors of cathepsin s |
| IL155961A0 (en) | 2000-11-17 | 2003-12-23 | Medivir Uk Ltd | Cysteine protease inhibitors |
| WO2002051983A2 (en) | 2000-12-22 | 2002-07-04 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions as cathepsin inhibitors |
-
2002
- 2002-01-17 PT PT02732145T patent/PT1362052E/pt unknown
- 2002-01-17 MX MXPA03006224A patent/MXPA03006224A/es active IP Right Grant
- 2002-01-17 BR BR0206501-0A patent/BR0206501A/pt not_active IP Right Cessation
- 2002-01-17 ES ES02732145T patent/ES2281516T3/es not_active Expired - Lifetime
- 2002-01-17 JP JP2002557947A patent/JP4608183B2/ja not_active Expired - Fee Related
- 2002-01-17 IL IL15677402A patent/IL156774A0/xx active IP Right Grant
- 2002-01-17 NZ NZ526913A patent/NZ526913A/xx not_active IP Right Cessation
- 2002-01-17 AU AU2002219397A patent/AU2002219397B2/en not_active Ceased
- 2002-01-17 DK DK02732145T patent/DK1362052T3/da active
- 2002-01-17 KR KR1020037009524A patent/KR100860067B1/ko not_active Expired - Fee Related
- 2002-01-17 CN CNB028038142A patent/CN1269822C/zh not_active Expired - Fee Related
- 2002-01-17 EP EP02732145A patent/EP1362052B1/en not_active Expired - Lifetime
- 2002-01-17 DE DE60218633T patent/DE60218633T2/de not_active Expired - Lifetime
- 2002-01-17 WO PCT/GB2002/000184 patent/WO2002057270A1/en not_active Ceased
- 2002-01-17 RU RU2003125270/04A patent/RU2329266C2/ru not_active IP Right Cessation
- 2002-01-17 CA CA2436462A patent/CA2436462C/en not_active Expired - Fee Related
- 2002-01-17 US US10/466,384 patent/US7425562B2/en not_active Expired - Fee Related
- 2002-01-17 AT AT02732145T patent/ATE356130T1/de active
-
2003
- 2003-07-03 IL IL156774A patent/IL156774A/en not_active IP Right Cessation
- 2003-07-16 NO NO20033220A patent/NO328208B1/no not_active IP Right Cessation
-
2007
- 2007-06-04 CY CY20071100742T patent/CY1106640T1/el unknown
-
2008
- 2008-09-15 US US12/211,069 patent/US20090247471A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030075161A (ko) | 2003-09-22 |
| DE60218633T2 (de) | 2008-02-21 |
| CY1106640T1 (el) | 2012-01-25 |
| WO2002057270A1 (en) | 2002-07-25 |
| NO328208B1 (no) | 2010-01-11 |
| ES2281516T3 (es) | 2007-10-01 |
| US7425562B2 (en) | 2008-09-16 |
| DE60218633D1 (de) | 2007-04-19 |
| RU2329266C2 (ru) | 2008-07-20 |
| ATE356130T1 (de) | 2007-03-15 |
| BR0206501A (pt) | 2004-01-13 |
| DK1362052T3 (da) | 2007-07-09 |
| CA2436462A1 (en) | 2002-07-25 |
| RU2003125270A (ru) | 2005-02-20 |
| KR100860067B1 (ko) | 2008-09-24 |
| EP1362052A1 (en) | 2003-11-19 |
| IL156774A (en) | 2008-08-07 |
| US20090247471A1 (en) | 2009-10-01 |
| EP1362052B1 (en) | 2007-03-07 |
| HK1060729A1 (en) | 2004-08-20 |
| PT1362052E (pt) | 2007-04-30 |
| JP4608183B2 (ja) | 2011-01-05 |
| AU2002219397B2 (en) | 2008-02-14 |
| NZ526913A (en) | 2004-12-24 |
| CN1486320A (zh) | 2004-03-31 |
| IL156774A0 (en) | 2004-02-08 |
| NO20033220D0 (no) | 2003-07-16 |
| MXPA03006224A (es) | 2004-10-15 |
| NO20033220L (no) | 2003-09-17 |
| CA2436462C (en) | 2011-07-05 |
| JP2004518674A (ja) | 2004-06-24 |
| US20040138250A1 (en) | 2004-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1486320A (zh) | 克鲁兹蛋白酶与其他半胱氨酸蛋白酶的抑制剂 | |
| CN1280269C (zh) | 脂肪族含氮五员环化合物 | |
| CN1681817A (zh) | 生物活性化合物 | |
| CN1299677C (zh) | 丙型肝炎病毒抑制剂 | |
| CN1151787C (zh) | 乳胱氨酸类似物 | |
| CN100351253C (zh) | 作为免疫抑制剂的吡咯并[2,3-d]嘧啶化合物 | |
| CN100339389C (zh) | 丙型肝炎三肽抑制剂 | |
| CN1894274A (zh) | 丙肝病毒ns3丝氨酸蛋白酶的大环抑制剂 | |
| CN1950393A (zh) | 丙型肝炎病毒ns3蛋白酶的抑制剂 | |
| CN1890215A (zh) | 丙型肝炎病毒ns3/ns4a丝氨酸蛋白酶的抑制剂 | |
| CN101076516A (zh) | 作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的硫化合物 | |
| CN1441806A (zh) | 包含n-环p2部分的丙型肝炎病毒的大环ns3-丝氨酸蛋白酶抑制剂 | |
| CN1946691A (zh) | 作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的化合物 | |
| CN1741986A (zh) | 酰胺衍生物及其作为11-β羟类固醇脱氢酶抑制剂的用途 | |
| CN1432022A (zh) | 含有烷基和芳基丙氨酸p2部分的丙型肝炎病毒的大环ns3-丝氨酸蛋白酶抑制剂 | |
| CN1064683A (zh) | 新的β-氨基-α羟基羧酸及其用途 | |
| CN100344632C (zh) | 稠合的呋喃化合物 | |
| CN1623984A (zh) | 稠环化合物及其药物用途 | |
| CN1914207A (zh) | 作为药物的氮杂䓬并吲哚衍生物 | |
| CN1894234A (zh) | 二肽基肽酶抑制剂 | |
| CN1217186A (zh) | 含氢化吡啶衍生物作为其活性成分的药用组合物的制备方法 | |
| CN1258294A (zh) | 2-氧代咪唑衍生物 | |
| CN101039672A (zh) | 化合物 | |
| CN1902172A (zh) | 用于治疗代谢障碍的作为11-β-HSD1抑制剂的N-酰化-3-(苯甲酰基)-吡咯烷类化合物 | |
| CN1049219C (zh) | 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1060729 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: GRUENENTHAL GMBH Free format text: FORMER OWNER: AMURA THERAPEUTICS LTD. Effective date: 20131008 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20131008 Address after: Aachen Patentee after: Gruenenthal Chemie Address before: cambridge Patentee before: Amura Therapeutics Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060816 Termination date: 20180117 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |